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Is exercise treadmill testing
useful for detecting 
heart disease in women?
■ EVIDENCE-BASED ANSWER
Exercise treadmill testing has a sensitivity of
70% and specificity of 61% for the detection of
coronary artery disease (CAD) in women
(strength of recommendation [SOR]: A, based
on a meta-analysis). It is useful for detecting
CAD in symptomatic women who have an inter-
mediate risk as determined by age and symp-
toms (SOR: C, based on expert opinion).
Exercise treadmill testing may also have an
application in determining exercise capacity and
potential as a tool to predict cardiovascular
death in women (SOR: A, cohort study).
■ EVIDENCE-BASED SUMMARY
Few studies of exercise treadmill testing
include a significant number of women, which
makes it difficult to ascertain its value for
detecting CAD in women. A large meta-analysis
of 19 studies looked specifically at women
(n=3721) and found that noninvasive exercise
tests only “moderately useful” for the detection
of CAD. Exercise treadmill testing in women had
a specificity of 0.70 (95% confidence interval
[CI], 0.64–0.75), a sensitivity of 0.61 (95% CI,
0.54–0.68), a positive likelihood ratio of 2.25
(95% CI, 1.84–2.66) and a negative likelihood
ratio of 0.55 (95% CI, 0.47–0.62). In comparison,
exercise treadmill testing in men had a sensitivi-
ty of 0.70 and a specificity of 0.77.1 The Table
demonstrates how exercise treadmill testing per-
forms for different levels of pretest probability.
Among the theoretical reasons for the dimin-
ished accuracy of the exercise treadmill testing
in women are the varying catecholamine
response to exercise, a higher incidence of
mitral valve prolapse, and chest wall anatomy
different than that in men.1 Also, the methods
used in performing exercise treadmill testing, as
well as the thresholds for an abnormal test
result, were established for men. Accuracy may
also be affected by the subjectivity inherent in
the performance and interpretation of the exer-
cise treadmill testing, in particular, the reading
of the ST segment.2
A large cohort study of 2994 asymptomatic
women found that those women with a below-
average peak exercise capacity and heart-rate
recovery rate were 3.5 times more likely to die
of cardiovascular causes than women who were
above average (95% CI, 1.57–7.86).3 Another
cohort study of 5721 women found that an exer-
cise capacity of <5 metabolic equivalents
(METS) tripled the risk of death as compared
with those with an exercise capacity of >8
METS.4 These studies support the role of exer-
cise treadmill testing for risk stratification for
CAD disease in women. 
■ RECOMMENDATIONS FROM OTHERS
The Institute for Clinical Systems Improvement
states that exercise treadmill testing has appli-
cation for the detection of coronary artery dis-
ease in those women with an intermediate
(10%–90%) pretest probability of coronary
artery disease as determined by age, gender,
and symptoms. The intermediate category
includes women aged 30 to 49 years with typi-
cal symptoms of angina, women aged 50 to 59
years with typical or atypical symptoms of angi-
na, and women aged 60 to 69 years with atypi-
cal or nonanginal chest pain. All other women
fall into groups with pretest probability either
high enough or low enough that the exercise
treadmill testing is less useful.5
The American College of Cardiology (ACC)
and the American Heart Association concluded
that the diagnosis of CAD in women presents
difficulties not experienced with men, due 
primarily to the lower sensitivity and specificity
of exercise treadmill testing. The ACC recom-
mends exercise treadmill testing for the diagno-
sis of CAD in patients with an intermediate
pretest probability of coronary disease based on
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age, gender, and symptoms. (This recommenda-
tion is described as one for which there is 
evidence or general agreement that a given pro-
cedure or treatment is useful and effective.)6
Jessie Junker, MD, MBA, Albert Meyer, MD,
New Hanover Regional Medical Center, Wilmington, NC;
Donna Flake, MSLS, MSAS, Coastal AHEC Library,
Wilmington, NC
■ CLINICAL COMMENTARY
False-positive rate and costs may argue
for stress radionuclide or echocardiogram
The relative lack of evidence regarding the
diagnostic accuracy of exercise treadmill test-
ing in women is frustrating given the preva-
lence of both CAD and symptoms of chest pain
in women. Nevertheless, it seems clear that
the false-positive rate and costs argue that
unless a woman meets specific criteria (eg,
International Sensitivity Index recommenda-
tions), stress radionuclide or stress echocar-
diogram are better initial tests. I will use exer-
cise treadmill testing when evaluating exercise
capacity in my women patients.
Lynda Montgomery, MD, MEd, Case Western
Reserve University School of Medicine, University
Hospitals of Cleveland, Ohio
REFERENCES
1. Kwok Y, Kim C, Grady D, Segal M, Redberg R. Meta-analy-
sis of exercise testing to detect coronary artery disease in
women. Am J Cardiol 1999; 83:660–666.
2. Sketch MH, Mohiuddin SM, Lynch JD, Zencka AE, Runco
V. Significant sex differences in the correlation of electro-
cardiographic exercise testing and coronary arteriograms.
Am J Cardiol 1975; 36: 69–173.
3. Mora S, Redberg RF, Cui Y, et al. Ability of exercise test-
ing to predict cardiovascular and all cause death in
asymptomatic women: a 20-year follow-up of the lipid
research clinics prevalence study. JAMA 2003;
290:1600–1607.
4. Gulati M, Pandey DK, Arnsdorf MF, et al. Exercise capac-
ity and the risk of death in women: the St. James Women
Take Heart Project. Circulation 2003; 108:1554–1559.
5. Institute for Clinical Systems Improvement. Health Care
Guidelines Supplement: Cardiac Stress Test Supplement.
October 2002. Available at:  www.icsi.org/knowledge/
detail.asp?catID=29&itemID=155. Accessed on March 9,
2004.
6. American College of Cardiology/American Heart
Association 2002 Guideline. Update for the Management of
Patients with Chronic Stable Angina. Available at:
www.acc.org/clinical/guidelines/stable/stable_clean.pdf.
Accessed on March 9, 2004.
Want more Clinical Inquiries? 
Visit the archive at
www.jfponline.com
Post-test probabilities of coronary artery disease 
using exercise echocardiogram
Post-test probability of CAD
Pretest symptoms/
probability of CAD Positive test ( %) Negative test (%)
Definite angina— 85 57
71% probability
Probable angina— 50 20
31% probability
Nonspecific chest pain— 13 3
6% probability
CAD, coronary artery disease.
Table adapted from Kwok et al 1999.
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